Application Information

This drug has been submitted to the FDA under the reference 021856/001.

Names and composition

"ULORIC" is the commercial name of a drug composed of FEBUXOSTAT.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021856/001 ULORIC FEBUXOSTAT TABLET/ORAL 40MG
021856/002 ULORIC FEBUXOSTAT TABLET/ORAL 80MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021856/001 ULORIC FEBUXOSTAT TABLET/ORAL 40MG
021856/002 ULORIC FEBUXOSTAT TABLET/ORAL 80MG
205385/001 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 40MG
205385/002 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 80MG
205406/002 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 80MG
205414/001 FEBUXOSTAT FEBUXOSTAT TABLET/ ORAL 40MG
205414/002 FEBUXOSTAT FEBUXOSTAT TABLET/ ORAL 80MG
205421/001 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 40MG
205421/002 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 80MG
207293/001 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 40MG
207293/002 FEBUXOSTAT FEBUXOSTAT TABLET/ORAL 80MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved